Abstract
Objective
To investigate the potential efficacy of panaxadiol saponins component (PDS-C), a biologically active fraction isolated from total ginsenosides, to reverse chemotherapy-induced myelosuppression and pancytopenia caused by cyclophamide (CTX).
Methods
Mice with myelosuppression induced by CTX were treated with PDS-C at a low- (20 mg/kg), moderate- (40 mg/kg), or high-dose (80 mg/kg) for 7 consecutive days. The level of peripheral white blood cell (WBC), neutrophil (NEU) and platelet (PLT) were measured, the histopathology and colony formation were observed, the protein kinase and transcription factors in hematopoietic cells were determined by immunohistochemical staining and Western blot.
Results
In response to PDS-C therapy, the peripheral WBC, NEU and PLT counts of CTX-induced myelosuppressed mice were significantly increased in a dose-dependent manner. Similarly, bone marrow histopathology examination showed reversal of CTX-induced myelosuppression with increase in overall bone marrow cellularity and the number of hematopoietic cells (P<0.01). PDS-C also promoted proliferation of granulocytic and megakaryocyte progenitor cells in CTX-treated mice, as evidenced by significantly increase in colony formation units-granulocytes/monocytes and -megakaryocytes (P<0.01). The enhancement of hematopoiesis by PDS-C appears to be mediated by an intracellular signaling pathway, this was evidenced by the up-regulation of phosphorylated mitogen-activated protein kinase (p-MEK) and extracellular signal-regulated kinases (p-ERK), and receptor tyrosine kinase (C-kit) and globin transcription factor 1 (GATA-1) in hematopoietic cells of CTX-treated mice (P<0.05).
Conclusions
PDS-C possesses hematopoietic growth factor-like activities that promote proliferation and also possibly differentiation of hematopoietic progenitor cells in myelosuppressed mice, probably mediated by a mechanism involving MEK and ERK protein kinases, and C-kit and GATA-1 transcription factors. PDS-C may potentially be a novel treatment of myelosuppression and pancytopenia caused by chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Newman NB, Sidhu MK, Baby R, Moss RA, Nissenblatt M J, Chen T, et al. Long-term bone marrow suppression during postoperative chemotherapy in rectal cancer patients after preoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys 2016;94:1052–1060.
Feng L, Huang Q, Huang Z, Li H, Qi X, Wang Y, et al. Optimized animal model of CTX-induced bone marrow suppression. Basic Clin Pharmacol Toxicol 2016;119:428–435.
Kadri SS, Remy KE, Strich JR, Gea-Banacloche J, Leitman SF. Role of granulocyte transfusions in invasive fusariosis: systematic review and single-center experience. Transfusion 2015;55:2076–2085.
Cines DB, Gernsheimer T, Wasser J, Godeau B, Provan D, Lyons R, et al. Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim. Int J Hematol 2015;102:259–270.
Lee JI, Ha YW, Choi TW, Kim HJ, Kim SM, Jang HJ, et al. Cellular uptake of ginsenosides in Korean white ginseng and red ginseng and their apoptotic activities in human breast cancer cells. Planta Med 2011;77:133–140.
Zheng Y, Nan H, Hao M, Song C, Zhou Y, Gao Y. Antiproliferative effects of protopanaxadiol ginsenosides on human colorectal cancer cells. Biomed Rep 2013;1:555–558.
Lee DG, Jang SI, Kim YR, Yang KE, Yoon SJ, Lee ZW, et al. Anti-proliferative effects of ginsenosides extracted from mountain ginseng on lung cancer. Chin J Integr Med 2016;22:344–352.
Gao RL, Xu CL, Jin JM. Effect of total saponins of Panax ginseng on hematopoietic progenitor cells in normal human and aplastic anemia patients. Chin J Integr Tradit West Med (Chin) 1992;12:285–287,261-282.
Chen XH, Gao RL, Xu WH. Effect of ginsenosides in inducing proliferation and transcription factor of erythrocytic, granulo-monocytic and megakarocytic cell lines. Chin J Integr Tradit West Med (Chin) 2001;21:40–42.
Gao RL. Research and development of new Chinese materia medica for treatment of refractory hematopathy by establishment and application of multiple technique platforms. Chin J Integr Med 2007;13:95–97.
Jin J, Tao H, Gao R. Effect of ginsenosides on proliferation and differentiation of human CD34+ hematopoietic stem/progenitor cells. Chin J Integr Tradit West Med (Chin) 2000;20:673–676.
Kuang YM, Zhu Y, Gao RL, Hu J, Jiang ZY, Huang L, et al. Clinical study of Pai-Neng-Da Capsule in the treatment of chronic aplastic anemia. Chin J Integr Med 2016;22:124–129.
Gao RL, Chong BH. Research and development of the effective components of panaxdiol saponin as new Chinese patent medicine for treating hemocytopenia. Chin J Integr Med 2012;18:897–902.
Fang GL, Gao RL, Lin XJ, Jin JM. Effects of Ginseng panaxadiol saponin on proliferation and differentiation of human bone marrow CD34+ cells. J Exp Hematol (Chin) 2007;15:776–779.
Lin X, Yin L, Gao R, Liu Q, Xu W, Jiang X, et al. The effects of panaxadiol saponins on megakaryocytic maturation and immune function in a mouse model of immune thrombocytopenia. Exp Hematol 2015;43:364–373.
Wen WW, Sun X, Zhuang HF, Lin XJ, Zheng ZY, Gao RL, et al. Effects of panaxadiol saponins component as a new Chinese patent medicine on proliferation, differentiation and corresponding gene expression profile of megakaryocytes. Chin J Integr Med 2016;22:28–35.
Xu SF, Yu LM, Fan ZH, Wu Q, Yuan Y, Wei Y, Fang N. Improvement of ginsenoside Rg1 on hematopoietic function in cyclophosphamide-induced myelosuppression mice. Eur J Pharmacol 2012;695:7–12.
Gao RL, Chen XH, Lin XJ, Qian XD, Xu WH, Chong BH. Effects of notoginosides on proliferation and upregulation of GR nuclear transcription factor in hematopoietic cells. Acta Pharmacol Sin 2007;28:703–711.
Sun X, Gao RL, Lin XJ, Xu WH, Chen XH. Panax notoginseng saponins induced up-regulation, phosphorylation and binding activity of MEK, ERK, AKT, PI-3K protein kinases and GATA transcription factors in hematopoietic cells. Chin J Integr Med 2013;19:112–118.
Gao RL, Xu WH, Lin XJ, Chen XH, Wu CQ. Up-regulation of transcription factors GATA-1 and GATA-2 induced by Panax notoginosides in hematopoietic cells. Chin J Hematol (Chin) 2004;25:281–284.
Zhang Y, Dong C. Regulatory mechanisms of mitogen-activated kinase signaling. Cell Mol Life Sci 2007;64:2771–2789.
Lennartsson J, Ronnstrand L. Stem cell factor receptor/C-kit: from basic science to clinical implications. Physiol Rev 2012;92:1619–1649.
Millikan PD, Balamohan SM, Raskind WH, Kacena MA. Inherited thrombocytopenia due to GATA-1 mutations. Semin Thromb Hemost 2011;37:682–689.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the Science and Technology Program Project of Zhejiang Province (No. 2015C33173), and Chinese Medicine Foundation of Young Talents in Zhejiang Province (No. 2014ZQ006), Australia-China Institutional Links Research Program sponsored by the International Development Program of Education Australia (No. IDP 2-8)
Rights and permissions
About this article
Cite this article
Sun, X., Zhao, Yn., Qian, S. et al. Ginseng-Derived Panaxadiol Saponins Promote Hematopoiesis Recovery in Cyclophosphamide-Induced Myelosuppressive Mice: Potential Novel Treatment of Chemotherapy-Induced Cytopenias. Chin. J. Integr. Med. 24, 200–206 (2018). https://doi.org/10.1007/s11655-017-2754-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-017-2754-8